Pharmafile Logo
Pharmafocus logo
Advanced Search

Lord Jim O’Neill

Showing 3 posts of 3 posts found.

AMR advisor calls for public utility company to tackle AMR

March 28, 2019
Medical Communications, Research and Development AMR, Lord Jim O'Neill, antimicrobial resistance, pharma, public health

Lord Jim O’Neill, an economist and former government advisor on antimicrobial resistance (AMR), has accused the pharmaceutical industry of “spewing …

News

Urgent action needed on antimicrobial resistance, says government report

May 19, 2016
Manufacturing and Production, Medical Communications, Research and Development ABPI, Lord Jim O'Neill, NICE, antimicrobial resistance

A new UK governmental report has warned that the global rise of antimicrobial resistance is set to worsen, with the …

News
WEF

Pharma leads global call for action on antimicrobial resistance

January 21, 2016
Manufacturing and Production, Research and Development Davos, Lord Jim O'Neill, Review on antimicrobial resistance, World Economic Forum, antibiotic resistance, antimicrobial resistance

More than 70 leading international pharmaceutical and biotechnology companies, as well as industry associations, have come together to call for …

News

Latest content

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024

Ascendis Pharma’s Yorvipath approved by MHRA for hypoparathyroidism treatment

April 25, 2024

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024